NASDAQ:GNMX Investor Alert: Investigation over Potential Wrongdoing at Aevi Genomic Medicine, Inc
May 11, 2018 at 12:22 PM EDT
San Diego, CA -- (SBWIRE) -- 05/11/2018 -- An investigation was announced for investors in shares of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) concerning possible breaches of fiduciary duties by certain officers and directors at Aevi Genomic Medicine, Inc.